These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

144 related articles for article (PubMed ID: 4272383)

  • 1. Degradation of human fibrinogen by Brinastrase, trypsin and chymotrypsin. An immunological study.
    Gormsen J; Feddersen C; Andersen RB
    Scand J Haematol; 1973; 10(5):349-57. PubMed ID: 4272383
    [No Abstract]   [Full Text] [Related]  

  • 2. Degradation of non cross-linked and cross-linked fibrin clots by plasmin, trypsin, chymotrypsin and Brinase.
    Gormsen J; Feddersen C
    Thromb Res; 1974 Aug; 5(2):125-39. PubMed ID: 4278050
    [No Abstract]   [Full Text] [Related]  

  • 3. Degradation of plasmin-resistant fibrinogen-fibrin breakdown products in rheumatoid synovial fluid by Brinastrase.
    Andersen RB; Gormsen J
    Scand J Rheumatol; 1973; 2(2):81-6. PubMed ID: 4270793
    [No Abstract]   [Full Text] [Related]  

  • 4. The structure of the fibrinogen degradation products.
    Marder VJ; Budzynski AZ
    Prog Hemost Thromb; 1974; 2(0):141-74. PubMed ID: 4137300
    [No Abstract]   [Full Text] [Related]  

  • 5. Degradation of fibrinogen in vitro. Demonstration of several antigenic intermediates by specific anti-D and anti-E serum.
    Gormsen J; Feddersen C; Clemmensen I; Andersen RB
    Scand J Haematol; 1972; 9(6):577-86. PubMed ID: 4118846
    [No Abstract]   [Full Text] [Related]  

  • 6. Degradation of human fibrinogen by chymotrypsin-like neutral protease from human granulocytes.
    Gramse M; Bingenheimer C; Havemann K
    Thromb Res; 1980 Jul 1-15; 19(1-2):201-9. PubMed ID: 6160637
    [No Abstract]   [Full Text] [Related]  

  • 7. High molecular weight derivatives of human fibrinogen produced by plasmin. I. Physicochemical and immunological characterization.
    Marder VJ; Shulman NR; Carroll WR
    J Biol Chem; 1969 Apr; 244(8):2111-9. PubMed ID: 4238527
    [No Abstract]   [Full Text] [Related]  

  • 8. Degradation of fibrinogen by proteolytic enzymes.
    Latallo ZS; Teisseyre E; Wegrzynowicz Z; Kopéc M
    Scand J Haematol Suppl; 1971; 13():15-9. PubMed ID: 4258200
    [No Abstract]   [Full Text] [Related]  

  • 9. [Contribution on the immunology of rabbit fibrinogen].
    Krantz S
    Acta Biol Med Ger; 1968; 21(3):385-96. PubMed ID: 4973966
    [No Abstract]   [Full Text] [Related]  

  • 10. The essential covalent structure of human fibrinogen evinced by analysis of derivatives formed during plasmic hydrolysis.
    Mosesson MW; Finlayson JS; Galanakis DK
    J Biol Chem; 1973 Nov; 248(22):7913-29. PubMed ID: 4127218
    [No Abstract]   [Full Text] [Related]  

  • 11. Fibrinogen-fibrin breakdown products in pathologic synovial fluids. An immunologic study.
    Gormsen J; Andersen RB; Feddersen C
    Arthritis Rheum; 1971; 14(4):503-12. PubMed ID: 4254709
    [No Abstract]   [Full Text] [Related]  

  • 12. Plasmic degradation of human fibrinogen. II. Further characterization of fragment D.
    Furlan M; Beck EA
    Biochim Biophys Acta; 1973 May; 310(1):205-16. PubMed ID: 4197006
    [No Abstract]   [Full Text] [Related]  

  • 13. Survival of rabbit platelets treated in vitro with chymotrypsin, plasmin, trypsin, or neuraminidase.
    Greenberg JP; Packham MA; Guccione MA; Rand ML; Reimers HJ; Mustard JF
    Blood; 1979 May; 53(5):916-27. PubMed ID: 155482
    [No Abstract]   [Full Text] [Related]  

  • 14. Proteolytic enzymes and biological inhibitors. V. Serological relationship between bovine and swine trypsins and bovine -chymotrypsin.
    Fossum K
    Acta Vet Scand; 1971; 12(3):417-28. PubMed ID: 4109881
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effect of various proteolytic enzymes on fibrinogen.
    Latallo ZS; Teisseyre E; Wegrzynowicz Z; Kopec M
    Folia Haematol Int Mag Klin Morphol Blutforsch; 1971; 95(2):158-66. PubMed ID: 4106004
    [No Abstract]   [Full Text] [Related]  

  • 16. Characterization of fibrin degradation products in patients on ancrod therapy: comparison with fibrinogen derivatives produced by plasmin.
    Prentice CR; Edgar W; McNicol GP
    Br J Haematol; 1974 May; 27(1):77-87. PubMed ID: 4277400
    [No Abstract]   [Full Text] [Related]  

  • 17. Antigenic and immunological characteristics of tryptic and chymotryptic subfragments from the C 3 homology region of human immunoglobulin G.
    Turner MW; Komvopoulos A; Bennich H; Natvig JB
    Scand J Immunol; 1972; 1(1):53-62. PubMed ID: 4672610
    [No Abstract]   [Full Text] [Related]  

  • 18. Degradation of fibrinogen by proteolytic enzymes. I. Characterization and isolation of products and their relation to fibrinolytic states.
    Sanchez-Avalos J; Miller SP
    Thromb Diath Haemorrh; 1968 Jul; 19(3):499-515. PubMed ID: 4974324
    [No Abstract]   [Full Text] [Related]  

  • 19. Effects of enzymatic degradation on the subunit composition and biologic properties of human factor VIII.
    Atichartakarn V; Marder VJ; Kirby EP; Budzynski AZ
    Blood; 1978 Feb; 51(2):281-97. PubMed ID: 145884
    [No Abstract]   [Full Text] [Related]  

  • 20. Identification and purification of fibrinogen degradation products produced by plasmin: considerations on the structure of fibrinogen.
    Marder VJ
    Scand J Haematol Suppl; 1971; 13():21-36. PubMed ID: 4258202
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 8.